About NET CONNECT
NET CONNECT is a group of both established and next-generation international experts in the field of neuroendocrine tumors (NET). The Steering Committee and Members aim to collaborate in scientific activities, share best practices and discuss the latest scientific and clinical insights to develop educational programs, supporting medical oncologists, endocrinologists and gastroenterologists around the world to provide the best possible care to their patients.
Please submit your clinical topic for the next NET CONNECT newsletter.
Subscribe to the NET CONNECT newsletter to receive monthly updates.
Neuroendocrine tumour update by Dr. Angela Lamarca, The Christie NHS Foundation Trust / University of Manchester, UK
Dr. Jaume Capdevila, a Medical Oncologist at Vall d’Hebron University Hospital in Barcelona, Spain, and Dr. Rachel van Leeuwaarde, an Endocrinologist from the University Medical Center of Utrecht in The Netherlands discuss the use of multi-kinase inhibitors (MKIs).